1 Introduction Abdominal obesity is associated with an increased risk for systemic inflammation, hypertension, type II diabetes (T2D), cardiovascular disease (CVD), and mortality (Chait and den Hartigh 2020; Price et al. 2006). While abdominal obesity itself presents an increased risk for several metabolic abnormalities, conventional models of abdominal adiposity demonstrate that specific body fat (BF) distribution patterns, which vary by sex, differentially impact disease.